Diana Brazma

784 total citations
10 papers, 349 citations indexed

About

Diana Brazma is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Diana Brazma has authored 10 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Genetics and 3 papers in Rheumatology. Recurrent topics in Diana Brazma's work include Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). Diana Brazma is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). Diana Brazma collaborates with scholars based in United Kingdom and Bulgaria. Diana Brazma's co-authors include Elisabeth P. Nacheva, Duncan A. Clark, Hoe Nam Leong, Julie Howard, Colin Grace, Paul Griffiths, Claire Atkinson, Michael Potter, Katherine N. Ward and Annarosa Virgili and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and British Journal of Haematology.

In The Last Decade

Diana Brazma

10 papers receiving 346 citations

Peers

Diana Brazma

EPIDE

HEMAT

ONCOL

GENET

RHEUM

Julie Arrazi United Kingdom

Tanja Gromke Germany

C. Arthur United Kingdom

Geneviève Gallagher Canada

Julie Howard United Kingdom

Andrew McLarnon United Kingdom

H E Heslop United States

H L Grierson United States

J Maertens Belgium

Masamune Higashigawa Japan

Julie Arrazi United Kingdom

Diana Brazma

76 ×0.5

EPIDE

180 ×1.2

HEMAT

67 ×0.5

ONCOL

36 ×0.4

GENET

28 ×0.5

RHEUM

Citations per year, relative to Diana Brazma Diana Brazma (= 1×) peers Julie Arrazi

Countries citing papers authored by Diana Brazma

Since Specialization

Citations

This map shows the geographic impact of Diana Brazma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Brazma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Brazma more than expected).

Fields of papers citing papers by Diana Brazma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Brazma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Brazma. The network helps show where Diana Brazma may publish in the future.

Co-authorship network of co-authors of Diana Brazma

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Brazma. A scholar is included among the top collaborators of Diana Brazma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Brazma. Diana Brazma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Brazma, Diana, et al.. (2014). Can genome array screening replace FISH as a front‐line test in multiple myeloma?. Genes Chromosomes and Cancer. 53(8). 676–692. 11 indexed citations

2.

Virchis, Andres, Nicholas C.P. Cross, Diana Brazma, et al.. (2013). Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review. Molecular Cytogenetics. 6(1). 39–39. 19 indexed citations

3.

Nacheva, E, Colin Grace, Diana Brazma, et al.. (2013). Does BCR/ABL1 positive Acute Myeloid Leukaemia Exist?. British Journal of Haematology. 161(4). 541–550. 42 indexed citations

4.

Brazma, Diana, et al.. (2012). Imbalances of Chromosome 21 in MDS/AML Include Cryptic Deletions but NOT RUNX1 Amplifications.. Blood. 120(21). 2561–2561. 1 indexed citations

5.

Nacheva, Elisabeth P., Diana Brazma, A.C. Virgili Manrique, et al.. (2010). Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia. BMC Genomics. 11(1). 41–41. 38 indexed citations

6.

Brazma, Diana, et al.. (2009). Copy Number Variants: Distribution in Patients with Coronary Atherosclerosis. Biotechnology & Biotechnological Equipment. 23(1). 1095–1100. 2 indexed citations

7.

Nacheva, Elisabeth P., Katherine N. Ward, Diana Brazma, et al.. (2008). Human herpesvirus 6 integrates within telomeric regions as evidenced by five different chromosomal Sites. Journal of Medical Virology. 80(11). 1952–1958. 64 indexed citations

8.

Manrique, A.C. Virgili, Diana Brazma, Alistair Reid, et al.. (2008). FISH mapping of Philadelphia negative BCR/ABL1 positive CML. Molecular Cytogenetics. 1(1). 14–14. 27 indexed citations

9.

Brazma, Diana, C. Grace, Julie Howard, et al.. (2007). Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression. Genes Chromosomes and Cancer. 46(11). 1039–1050. 39 indexed citations

10.

Clark, Duncan A., Elisabeth P. Nacheva, Hoe Nam Leong, et al.. (2006). Transmission of Integrated Human Herpesvirus 6 through Stem Cell Transplantation: Implications for Laboratory Diagnosis. The Journal of Infectious Diseases. 193(7). 912–916. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact